David Heredia, Head of the Oncology Department at Punta Médica, shared an article on X:
“New CA: A Cancer Journal for Clinicians review on EGFR-mutant NSCLC: All major trials.
Key poor prognostic clinical/molecular factors to guide care
A Must-read review.”
Title: Personalized care for patients with EGFR-mutant non-small cell lung cancer: Navigating early to advanced disease management
Authors: Maxime Borgeaud, Timothée Olivier, Jair Bar, Stephanie Saw, Kaushal Parikh, Giuseppe Banna, Claudio De Vito, Jill Feldman, Xiuning Le, Alfredo Addeo
Read the Full Article on CA: A Cancer Journal for Clinicians.
More posts featuring David Heredia.
